H7N9 Influenza Vaccine

Infectious Diseases
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Vaccine
1100%

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Medigen Vaccine Biologics
1 program
1
AT-501 High Dose vaccinePhase 1/2Vaccine1 trial
Active Trials
NCT02436928CompletedEst. Feb 2016

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Medigen Vaccine BiologicsAT-501 High Dose vaccine

Clinical Trials (1)

NCT02436928Medigen Vaccine BiologicsAT-501 High Dose vaccine

A Study to Evaluate the Safety and Immunogenicity of H7N9 Influenza Vaccine (AT-501) in Healthy Adult Subjects

Start: Apr 2015Est. completion: Feb 2016
Phase 1/2Completed

Related Jobs in Infectious Diseases

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space